Stock 4512 WAKAMOTO PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Wakamoto Pharmaceutical Co.,Ltd.

Equities

4512

JP3991200001

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-05 am EDT 		5-day change 1st Jan Change
255 JPY +0.39% Intraday chart for Wakamoto Pharmaceutical Co.,Ltd. -1.54% +19.72%
Jul. 02 Wakamoto Pharmaceutical Announces Voting Results CI
May. 15 Wakamoto Pharmaceutical Co., Ltd. Announces Notice on Shareholder Proposal CI

Business Summary

WAKAMOTO PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of ethical drugs such as gastrointestinal drugs and non-prescription drugs. The Company operates through four business segments. The Pharmaceuticals segment is involved in the manufacture and sale of innovator drugs, generic drugs and optiaid series supplements mainly in the ophthalmic field, as well as the commission of production and the sale of diagnostic drugs and raw materials in Japan. The Healthcare segment sales its core product Kawakami Wakamoto, the Avantbise series of medicated toothpastes that promote bad breath prevention based on evidence and Avantbise Oral Tablet mainly in the mail order business. The International segment is involved in the business related to the export of products and raw materials mainly in Asia and Europe, as well as the new license in and out business. The Real Estate Leasing segment is involved in the rental business of Coredo Muromachi.

Number of employees: 403

Sales per Business

JPY in Million2023Weight2024Weight Delta
Pharmaceutical
43.9 %
4,460 51.5 % 3,393 43.9 % -23.91%
Healthcare
31.7 %
2,001 23.1 % 2,453 31.7 % +22.56%
Global
22.2 %
2,019 23.3 % 1,718 22.2 % -14.90%
Real Estate Leasing
2.3 %
180 2.1 % 174 2.3 % -3.46%

Sales per region

JPY in Million2023Weight2024Weight Delta
Japan
100.0 %
7,472 86.3 % 7,738 100.0 % +3.57%

Managers

Managers TitleAgeSince
Arata Igarashi PSD
 President 65 10-04-30
Kimihiko Sato BRD
 Director/Board Member 58 88-03-31
Haruhisa Hirata BRD
 Director/Board Member 67 79-03-31
Kazuhiko Fukuhara IRC
 Investor Relations Contact - -
Hiroki Sanada SAM
 Sales & Marketing - -
Satoshi Naito PRN
 Corporate Officer/Principal 65 82-03-31
Masahiko Tanigaki SAM
 Sales & Marketing 64 83-03-31

Members of the board

Members of the board TitleAgeSince
Katsuyoshi Ejima BRD
 Director/Board Member 70 16-05-31
Haruhisa Hirata BRD
 Director/Board Member 67 79-03-31
Arata Igarashi PSD
 President 65 10-04-30
Masahiko Tanigaki SAM
 Sales & Marketing 64 83-03-31
Kimihiko Sato BRD
 Director/Board Member 58 88-03-31
Satoshi Naito PRN
 Corporate Officer/Principal 65 82-03-31
Toshio Watanabe BRD
 Director/Board Member 80 15-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 34,838,325 22,061,383 ( 63.33 %) 131,605 ( 0.3778 %) 63.33 %

Shareholders

NameEquities%Valuation
KISSEI PHARMACEUTICAL CO., LTD.
10.84 %
3,778,000 10.84 % 6 M ¥
Brastsheave Co. Ltd.
7.176 %
2,500,000 7.176 % 4 M ¥
Wakamoto Pharmaceutical Business Association.
5.528 %
1,926,000 5.528 % 3 M ¥
Asahi Mutual Life Insurance Co.
4.937 %
1,720,000 4.937 % 3 M ¥
THE CHIBA BANK, LTD.
3.795 %
1,322,000 3.795 % 2 M ¥
Nippon Zettoc Co., Ltd.
3.447 %
1,201,000 3.447 % 2 M ¥
AXA
3.238 %
1,128,000 3.238 % 2 M ¥
ROHTO PHARMACEUTICAL CO.,LTD.
3.172 %
1,105,000 3.172 % 2 M ¥
MIZUHO FINANCIAL GROUP, INC.
3.137 %
1,093,000 3.137 % 2 M ¥
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
1.444 %
503,000 1.444 % 813 019 ¥

Holdings

NameEquities%Valuation
ROHTO PHARMACEUTICAL CO.,LTD.
0.15%
 348,000 0.15% 6,114,276 $
KISSEI PHARMACEUTICAL CO., LTD.
0.41%
 200,000 0.41% 4,002,672 $
THE CHIBA BANK, LTD.
0.03%
 275,686 0.03% 2,620,109 $
TOHO HOLDINGS CO., LTD.
0.06%
 49,022 0.06% 1,238,769 $
ALFRESA HOLDINGS CORPORATION
0.04%
 86,024 0.04% 1,211,710 $
YOMEISHU SEIZO CO.,LTD.
0.38%
 62,500 0.38% 915,556 $
SUZUKEN CO., LTD.
0.02%
 18,579 0.02% 561,112 $
MEDIPAL HOLDINGS CORPORATION
0.02%
 37,300 0.02% 548,777 $
OHKI HEALTHCARE HOLDINGS CO.,LTD.
0.62%
 87,530 0.62% 524,138 $
MIZUHO FINANCIAL GROUP, INC.
0.00%
 19,342 0.00% 395,591 $

Company contact information

Wakamoto Pharmaceutical Co., Ltd.

2-2-2 Nihonbashi Hon-cho Chuo-Ku

103-8330, Tokyo

+

http://www.wakamoto-pharm.co.jp
address Wakamoto Pharmaceutical Co.,Ltd.(4512)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
WAKAMOTO PHARMACEUTICAL CO.,LTD. Stock Wakamoto Pharmaceutical Co.,Ltd.
+19.72% 55.21M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+56.89% 823B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.52% 627B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.55% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.99% 320B
ABBVIE INC. Stock AbbVie Inc.
+7.92% 295B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.74% 239B
NOVARTIS AG Stock Novartis AG
+13.83% 220B
ROCHE HOLDING AG Stock Roche Holding AG
-0.49% 219B
AMGEN INC. Stock Amgen Inc.
+7.94% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4512 Stock
  4. Company Wakamoto Pharmaceutical Co.,Ltd.